[Skip to Content]
[Skip to Content Landing]
June 1976

Cyanate-Induced Cataracts in Patients With Sickle-Cell Hemoglobinopathies

Author Affiliations

From the Bascom Palmer Eye Institute (Drs Nicholson and Benson) and the Department of Medicine (Dr Harkness), University of Miami School of Medicine and Veterans Administration Hospital, and the Laboratory of Medical Biochemistry, Rockefeller University, New York (Dr Peterson).

Arch Ophthalmol. 1976;94(6):927-930. doi:10.1001/archopht.1976.03910030465005

• Two young patients developed bilateral posterior subcapsular cataracts while receiving oral sodium cyanate for treatment of sickle cell hemoglobinopathy. In one of the patients, lens opacities regressed spontaneously after cyanate therapy was discontinued.